Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, N.
Right arrow Articles by Mori, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, N.
Right arrow Articles by Mori, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 1 133-137, Copyright © 1997 by American Diabetes Association


ARTICLES

Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients

N Sato, K Kashima, Y Tanaka, H Shimizu and M Mori
First Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.

To evaluate whether granulocyte-colony stimulating factor (G-CSF) improves an impaired production of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients, we studied the effect of G-CSF on myeloperoxidase (MPO) activity and chemiluminescence amplified by a Cypridina luciferin analog (CLA-DCL), which is dependent on O2 generation, and luminol (L-DCL), which is dependent on OCl(-) generation, in response to formyl-methonyl-leucyl-phenylalanine. Both CLA-DCL and L-DCL by neutrophils from the diabetic group (n = 15, HbA(1c) >10%) were significantly decreased (26 and 37%, respectively: P < 0.01) compared with the age-matched normal control group (n = 15), and L-DCL was more sensitive to this inhibition than CLA-DCL (P < 0.05). In both control and diabetic neutrophils, G-CSF significantly enhanced both CLA-DCL (175% in control and 156% in diabetic) and L-DCL (283% in control and 346% in diabetic). In diabetic neutrophils, the enhancing effect of G-CSF on L-DCL was more sensitive than on CLA-DCL (P < 0.001). There was a positive correlation between HbA(1c) and the enhancing effect of G-CSF on L-DCL in diabetic patients (P < 0.05), but not on CLA-DCL. MPO activity was also decreased in the diabetic group (63%, P < 0.05), and G-CSF improved this impaired MPO activity (184%, P < 0.01). Furthermore, there was a positive correlation between HbA(1c) and the improving effect of G-CSF on MPO activity (P < 0.05). Because bacterial infection still accounts for an important cause of morbidity and mortality in diabetic patients, these data suggest that G-CSF may be useful as a drug to prevent the aggravation of bacterial infection by improving neutrophil function, especially through H2O2-MPO-OCl(-) mechanism, in poorly controlled diabetic patients.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
M. Cruciani, B. A. Lipsky, C. Mengoli, and F. de Lalla
Are Granulocyte Colony-Stimulating Factors Beneficial in Treating Diabetic Foot Infections?: A meta-analysis
Diabetes Care, February 1, 2005; 28(2): 454 - 460.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. M. McManus, R. C. Bloodworth, T. J. Prihoda, J. L. Blodgett, and R. N. Pinckard
Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia
J. Leukoc. Biol., September 1, 2001; 70(3): 395 - 404.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
K. Sato, N. Sato, H. Shimizu, T. Tsutiya, H. Takahashi, S. Kakizaki, H. Takayama, H. Takagi, and M. Mori
Faropenem enhances superoxide anion production by human neutrophils in vitro
J. Antimicrob. Chemother., September 1, 1999; 44(3): 337 - 341.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Kashima, N. Sato, K. Sato, H. Shimizu, and M. Mori
Effect of Epalrestat, an Aldose Reductase Inhibitor, on the Generation of Oxygen-Derived Free Radicals in Neutrophils from Streptozotocin-Induced Diabetic Rats
Endocrinology, August 1, 1998; 139(8): 3404 - 3408.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.